Peres Jepchirchir: The Blood Ledger Behind the Sydney Win

On the morning of the Sydney Marathon, when Peres Jepchirchir crossed the line in 2:18:31, the gap to second place was over three minutes. Irene Chepet Cheptai's team had no answer. But the sample taken in Kenya before that race has now written a different story for the entire sport. The Athletics Integrity Unit (AIU) has provisionally suspended the 33-year-old Kenyan after an out-of-competition sample tested positive for EPO (erythropoietin). This is the same athlete who won Olympic gold in Tokyo 2026, World Championship gold in 2026, and the New York (2026), Boston (2026) and London (2026) marathons. Sydney 2026 was her seventh World Major title. EPO is not a foreign chemical. It is produced naturally in the kidneys and stimulates the production of red blood cells. Injected, it increases the number of red blood cells that carry oxygen to muscles. Crucially, it is detectable in urine or blood only within a short window. Athletes and their support teams often play with testing timing to exploit that window. Jepchirchir's sample was taken in Kenya before Sydney — meaning before the win. That is the most layered part of this case. If the sample was collected before the race and the result came later, the question arises: why was she allowed to run that race? The AIU's provisional suspension is now the basis of the investigation, but it is also clear that the time between the positive EPO result and the immediate suspension is an examination for sports administration. I learned in 2026, standing in the mixed zone at Kalinga Stadium, that the real story of athletics is not where the medals are. You also have to see whose urine was collected when, whose blood was tested when, and which form was filled after whose victory. In Jepchirchir's case, one fact stings the most: she broke the half-marathon world record in 2026 — not once, but three times. The first time in 2026. That was a period when Kenyan marathon running was among the most heavily tested areas for blood doping. AIU data from that time show that out-of-competition testing in Kenya increased rapidly. But the question is: did the increased density of testing stop EPO use, or merely change its timing? Jepchirchir's case suggests that until the result of a pre-race sample comes before the race, no testing framework can stop an athlete. This is not administrative delay; it is systemic failure. Now look at the side no one looks at. Jepchirchir's Sydney winning time was 2:18:31. That is extraordinary for the course, but it is not the time that won her both Olympic and World Championship gold. In Tokyo 2026 her time was 2:27:20 — slower due to heat and humidity. In the 2026 World Championships it was 2:24:12. In Sydney, 2:18:31 — an improvement of nearly six minutes, and that too at age 33, when marathon runners are typically in the latter half of their careers. The EPO allegation puts this improvement in a new light. But there is a nuance I record in my coverage ledger: the Sydney course and weather. This race became a World Major in 2026, and its route is relatively flat. It suits Kenyan runners. Yet the three-minute gap — over Cheptai — suggests that on that day Jepchirchir's physical capacity was on another level. The question is not how she won; it is who was keeping the ledger of that capacity. Jepchirchir's career symbolises an era when Kenyan women's marathon established its global dominance. But in that same era, tension between Kenya's national athletics body and the AIU also deepened. Since 2026, Kenya has been placed in the AIU's 'high risk' category, under which testing numbers were increased. At the time, it was argued that more testing would bring cleanliness. But in 2026, Jepchirchir's case suggests that the quantity of testing and its quality are two different things. Catching EPO requires more than a urine test; it requires blood profiling (the Athlete Biological Passport) and monitoring of sudden changes. In Jepchirchir's case, it is not clear whether her biological passport had been showing any signals. The AIU has not yet confirmed this. But if it hadn't, that is a big question: when an athlete is consistently winning major titles, how is she monitored? Here is another layer I connect to my 'quota and cheque' investigation method. In Kenya, athletics is not just sport; it is an economy. Prize money from a marathon win, sponsorships, and government grants — all create an ecosystem. An athlete like Jepchirchir has an entire team: coach, physio, manager, and sometimes medical advisors. EPO use is not done by the athlete alone; it is part of a planned process. The AIU investigation will now have to see what role Jepchirchir's team played after the sample was flagged. But in my experience, in such cases the first attempt is to protect the athlete, then the other team members. This is the reverse of 'duty of care' — those meant to care for the athlete push her into risk. After that Sydney race, when Jepchirchir said it was one of the biggest achievements of her career, no one asked when her last out-of-competition test was. In the mixed zone, we journalists ask 'how do you feel' and 'what is your next goal'. We do not ask 'when was your last blood sample taken and what was the result'. That is the gap I try to fill in my reporting. Jepchirchir's case shows that EPO is not just a chemical; it is a tool that makes an athlete invisibly stronger at a time when no one is watching. And in the marathon, where every step of 42 kilometres pushes the body to its limit, that invisible help is morally the greatest offence. One fact often missed in this case: Jepchirchir won the 2026 World Championships, and that race was held in Tokyo — the same city where she won 2026 Olympic gold. It was an emotional story that the media sold heavily. But no one dug into the testing record after that win. If we write only the story of victory and not the story of defeat or investigation, we fall prey to the same 'quadrennial parachute' journalism I want to avoid. Most reports after the Sydney Marathon focused on the 2:18:31 time and the three-minute gap. No one wrote that this race was awaiting the result of a pre-race sample. Now that the result is out, the same media is calling that same victory 'suspect'. Neither is right journalism. Right journalism is to ask before the race when the sample was taken and when the result will come, and after the race to report why the athlete was allowed to run until the result came. The second aspect of Jepchirchir's story is that she is not alone. Several other Kenyan women marathoners have faced EPO or other banned substance allegations in recent years. In 2026, another top Kenyan runner was suspended for EPO. A case also emerged in 2026. This is a pattern, and the pattern is not just individual. It points to a system where young athletes are pushed for early success, and banned substances are given in the name of medical support. Jepchirchir is 33, at the peak of her career, and has everything an athlete could want. If even she can fall into this trap, what about the young runners just starting out? The AIU's provisional suspension is a process, but that process is incomplete until it is proven why the sample result did not come before the race. I learned at Kalinga in 2026 that a journalist's job is not just to write records; she must also see at what cost the record was made. Jepchirchir's 2:18:31 is now entered in that ledger where I keep every out-of-competition test date and every winning time side by side. This ledger does not prove any athlete guilty; it asks who is keeping the account of her speed when an athlete runs this fast. The Sydney Marathon has now become another story — one where the joy of victory and the fear of investigation meet at the same finish line. For Jepchirchir, the next few months will be a legal battle. But for the sport, this is a chance to re-examine its testing framework. If the EPO sample was taken before the race, should the result have come before the race? And if not, should that race be declared 'undecided'? These questions are not just about Jepchirchir; they are about every athlete who will cross a finish line next. Until they are answered, that time of 2:18:31, and the blood ledger behind it, will remain on open pages.